HCPCS Level IIdrugActive

J0739

Hiv prep, inj, cabotegravir

BETOS: O1E

Effective: 2025-01-02

Referenced in 2 policies

Description

Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

Medicare Part B Drug Pricing

Average Sales Price (ASP) data for Q1 2026

Drug Name

Apretude

Manufacturer

VIIV HEALTHCARE

HCPCS Dosage

1 MG

Billing Units

600.0000

NDC Products

prep

Pricing Source

Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.